For research use only. We do not sell to patients.
Patritumab
CAS No. : 1262787-83-6
Biological Activity:Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors.
Research Area:Cancer
Targets:EGFR|Akt|PARP|Survivin|ERK
Related Small Molecules:Akt/NF-κB/JNK-IN-1;NSC81111;pp60 (v-SRC) Autophosphorylation Site, Phosphorylated;BMS-690514;Cyclovirobuxine D;Rucaparib monocamsylate;AZD-2461;Senaparib;Osimertinib-13C,d3;Dehydrocorydaline;AKTide-2T;EGFR-IN-5;FGFR2-IN-3;Rucaparib hydrochloride;Sennidin A;MS98;Niraparib tosylate;Genistein;Epertinib hydrochloride;PP2A Cancerous-IN-1;1,3-Dicaffeoylquinic acid;Sepantronium bromide;Corynoxeine;G007-LK;PROTAC PARP1 degrader;UNC-CA359;Artemisiane E;Osimertinib mesylate
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
- Structurally and synthetically diverse biologically active compounds;
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
- Customized order volume ranging from milligrams to kilograms scale;
Structurally and synthetically diverse biologically active compounds;
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.